4.4 Review

Inflammatory signaling in cartilage:: MAPK and NF-κB pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis

Journal

CURRENT DRUG TARGETS
Volume 8, Issue 2, Pages 305-313

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138945007779940115

Keywords

chondrocyte; MAP kinase; NF-kappa B; matrix metalloproteinase; protein kinase; protein kinase inhibitor; inflammatory response; osteoarthritis

Funding

  1. Medical Research Council [G8623776] Funding Source: Medline
  2. MRC [G8623776] Funding Source: UKRI
  3. Medical Research Council [G8623776] Funding Source: researchfish

Ask authors/readers for more resources

Osteoarthritis is characterised by degeneration of articular cartilage. It is thought to be primarily a disease of cartilage. Inflammatory response genes, such as proteinases, cyclooxygenase, and cytokines are implicated in its pathogenesis. The evidence for expression of these genes in articular cartilage in osteoarthritis is reviewed. The expression of inflammatory response genes is controlled by four major intracellular signalling pathways. These lead to activation of the three mitogen-activated protein kinases (MAPK) and the transcriptional regulator nuclear factor kappa (NF kappa)-B. The current state of knowledge of the structure of these pathways is summarized. Pharmacological inhibitors of the protein kinases of the pathways in current use are described, and insights into chondrocyte gene expression obtained with them are discussed. Very limited use of these inhibitors has yet been made in animal models of osteoarthritis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available